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ABSTRACT
Streptococcus suis is an emerging zoonotic human pathogen, which is a causative agent of invasive
infections in people who are in close contact with infected pigs or contaminated pork products. It is
associated with severe systemic infections, most commonly meningitis and sepsis, which may lead to
high rates of morbidity and mortality. Serotype 2 is the most prevalent type in S. suis infections in
humans. We have reported a case of a very rapidly proceeding fatal human S. suis infection in a
splenectomized, but otherwise immunocompetent patient in Hungary. We would like to highlight the
attention for this pathogen for the risk group patients, not only pig breeders, veterinarians, abattoir
workers, meat processing and transport workers, butchers and cooks, that those persons who are
immunocompromised including those with spleen removed, persons with diabetes mellitus, cancer and
alcoholism, are also at greater risk of infection.
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Streptococcus suis is a group of heterogeneous Gram-positive bacteria that were earlier
classified into the Lancefield groups R, S, and T. These bacteria are facultative anaerobes with
a spherical/ovoid shape which exist in short chains and/or pairs or as single bacteria. The
microorganisms show narrow zones of a-hemolysis when growing on selective plates of on
sheep or bovine blood agar plates. S. suis is an important zoonotic pathogen in mostly swines
and wild boars, but occurs in a wide range of animals and humans [1]. Clinical presentations
associated with this species in human infections are most frequently manifest as acute pu-
rulent bacterial meningitis, but include sepsis, streptococcal toxic shock-like syndrome
(STSLS) with multiple organ failure, endocarditis, and uveitis-endophthalmitis [2–4].
Generalized septicemia caused by S. suis may transform into arthritis, which affects different
types of joints such as hips, elbows, wrists, sacroiliac, spine, and thumbs. Permanent hearing
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sequelae of these infections [5]. Such infections are typically
sporadic, and in the majority of cases, occur in particular
occupational groups, such as pig breeders, veterinarians,
hunters, meat processing and transport workers, butchers
and cooks. According to literature data, skin injury in the
presence of pig/pork contact was described in 20–25% of the
published cases of S. suis infections [6]. S. suis may directly
pass into the bloodstream after exposure to pigs or pork/
bones in the presence of skin injuries, even without visible
wound infections. Infections may also be acquired by con-
tact with raw or undercooked meat products, traditionally
consumed in the Far East of Asia and, thus, S. suis should be
considered there as a food-borne pathogen. S. suis as a
pathogenic bacteria was initially reported by veterinarians in
1954, after outbreaks of meningitis, septicemia, and purulent
arthritis occurred among piglets [7]. The first published case
of S. suis meningitis in a human patient demonstrated as an
etiological agent for this kind of bacterial infection was in
Denmark in 1988 [8] and soon, some other cases were re-
ported in different Northern European countries and Hong
Kong. The interest in human infections caused by S. suis has
grown exponentially after the high morbidity-mortality rates
observed in Eastern-Asia countries, and human infections
have been now described worldwide [9–16]. Epidemiology
of infections differ among European–American countries
and different regions of Asia and the role of high-risk eating
habits (i.e., ingesting raw or undercooked pig parts,
including pig blood, organs) in some Asian communities has
been recently recognized [9–17]. According to Goyette-
Desjardins et al. [17], 1,642 cases of S. suis infections were
identified between 2002 and 2013 worldwide in humans, in a
total of 34 countries. Rates of S. suis infection are low in the
general population of Europe and North America, and cases
are concentrated among the exposed groups with other risk
factors. Hungary is a country in Central Europe, where the
breeding of pigs has long-lasting traditions, due to the
proclivity and preference of the general population to
consume pig meat. Therefore, there are a lot of people
working with these animals (farmers breeding or involved in
the transportation of pigs, dealing with the processing of
pork meat for consumption, e.g., butchers or workers in
meat plants), however, until this time only one case of hu-
man S. suis infection has been previously described in
Hungary, but only in the Hungarian-language literature in
Hungary [18].
S. suis a complex population consisting of heterogeneous
strains, which can be classified into 35 serotypes (1–34, 1/2)
based on the differentiation of capsule polysaccharide (CPS),
antigens, but most clinical isolates from reported human
cases were serotype 2 strains [19–21]. However, sporadic
human cases of other serotypes such as 1, 4, 5, 9, 14, 16, and
24 have also been reported, mostly in Southeast-Asian
countries. Still now, little is known factually about the
pathogenesis of S. suis infections and how the bacteria
crosses the blood-brain barrier. Inflammation is likely to
contribute to the manifestations of disease in pigs and
probably also in humans, as has been summarized in theliterature previously [22–24]. Bacteria may be transmitted to
patients through contamination, minor cuts or abrasions are
enough for the pathogen to be transmitted through the skin
of hands and/or arms causing a breach of skin integrity.
Some authors believe that the presence of multiple scars or
cuts on the hands of the patients facilitates the developing
the septic shock syndrome caused by S. suis after handling
animals [22–24]. Until now, more than 20 bacterial viru-
lence-associated factors have been identified, including
capsular polysaccharides (CPS), DNase (SsnA), extracellular
protein factor (EPF), suilysin (Sly), serum opacity factor
(OFS), some various adhesins: include fibronectin-binding
protein (FBP), muramidase-released protein (MRP), hya-
luronate lyase, surface antigen enolase (Eno) and surface
antigen one (Sao) [22–31]. Streptococcal toxic shock syn-
drome (STSS) and high mortality of patients, observed in
both big Chinese outbreaks, was attributed to the presence of
the 89K putative pathogenicity island (89K PAI) found in
strains which were responsible for these outbreaks [29].
Further studies suggested that 89K PAI with a transposon-
like essence can undergo GI-type T4SS-mediated horizontal
transfer in epidemic SS2 species, and to identify genes
encoding a two-component signal transduction system SalK/
SalR, a type IV-like secretion system and a novel hemolysis-
related gene hhly3, located within this element and pre-
sumably involved in the STSS development [22–31].
Capsular polysaccharide (CPS) a determinant of serotypes,
but it is also very important virulence factor and has high
anti-phagocytic effects against monocytes, neutrophils and
dendritic cells [19–21].CASE DESCRIPTION
A 34-year-old obese (BMI > 30) male patient was admitted
to the Emergency Unit of the University Hospital in Szeged,
due to very high fever (body temperature of 39.9 8C) and
unconsciousness. In his past medical history, splenectomy
was recorded 10 years ago due to a motorcycle accident. The
patient worked as a butcher in a local meat processing plant,
where he was injured on his hand by a pig bone one day
before hospital admission. On arrival to the emergency
room, he exhibited no neck stiffness or meningism, nor
peripheral stigmata of infective endocarditis; precordial ex-
amination revealed no audible cardiac murmur. At home,
the patient had high fever, chills, abdominal pain and watery
diarrhea. Relatives found the unconscious patient on the
floor of the sanitary room. XBLS (Extended Basic Life
Support) and later ALS (Advanced Life Support) were
started because of circulatory and respiratory failure. After
intubation and administration of epinephrine, spontaneous
circulation returned. Because of the possibility of sub-
arachnoid bleeding or pulmonary embolism, urgent cranial
and abdominal CT scans and pulmonary angiography were
carried out, and the patient was transferred to the ICU. CT
scans could not reveal any circulatory disorders, while cra-
nial CT showed right-sided, multiple, acute ischemic lesions.
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pertension was also noted. On admission to the ICU, severe
hypotension, sinus tachycardia and high fever were observed
in spite of intravenous dopamine. Using invasive cardio-
vascular monitoring, hydration and noradrenaline admin-
istration were applied. In spite of the PEEP (positive end-
expiratory pressure), adequate oxygenisation could not be
achieved, values for hypercapnic ventilator drives were
measured using blood gas analysis. The development of
respiratory and metabolic acidosis, severe hypoglycaemia
and hypokalemia were noted, thus supportive therapy
(ventilation, glucose, and potassium substitutions) were
introduced. High-dose vasopressor therapy was supple-
mented with epinephrine, but only transient increase in
blood pressure has been achieved. Renal function deterio-
rated and bleeding from each puncture site was noticed.
Simultaneously, petechiae in skin and mucous membranes
throughout the body could be observed. Laboratory in-
vestigations revealed severe coagulopathy, thrombocyto-
penia and fibrinolysis, thus alterations in hemostasis, for
which therapy has been initiated. Leukocyte cell count and
C-reactive protein were 17.03 109 L1 and 0.65 mg dL1,
respectively. Samples for microbiological investigation,
including duplicate blood culture pairs, urine samples,
faeces, sera for serology were immediately sent to the
microbiological laboratory. Empiric antibiotic therapy was
introduced (ceftriaxone and vancomycin), but in spite of
this, the patient’s condition did not improve; his blood
pressure was not stable, the oxygenisation did not improve
and the acidosis was persistent. Laboratory results showed
disseminated intravascular coagulation (DIC), acute renal,
and hepatic failures, while the result of a total microbio-
logical investigation of blood culture was given after the
patient died. S. suis was cultured from one pair of blood
culture bottles after 1 h of incubation and from the other
bottles after 4 h. Viral serology only revealed a past EBV
infection. The patient died within 12 h after hospital
admission from complications, such as DIC, acute renal
failure (ARF), and acute respiratory distress syndrome
(ARDS). Other toxic causes of metabolic catastrophe were
not verified. Postmortem examination of patients showed
features of DIC. Evidence of multiple organ damage was
observed, primarily involving lungs, liver, kidneys, histologic
findings included microthrombosis in organ capillaries; ne-
crosis of parenchymal cells; and congestion, exudate, and
hemorrhage of interstitial vessels of kidneys, lungs, and
other organs. The patient’s blood culture proved to be
positive for S. suis which was identified using matrix-assisted
laser desorption/ionization time of flight method (MALDI-
TOF) with a high log-score (2.324; score >2.3 indicates
“highly probable species identification”). The cultures were
identified as S. suis serotype 2 by polymerase chain reaction
(PCR) and specific sera [16]. The strain isolated from our
patient was resistant to clindamycin, erythromycin, clari-
thromycin and tetracycline, but susceptible to all tested
b-lactam antibiotics and vancomycin (note: susceptible/
resistant classifications employed for the breakpoints were
for viridans group streptococci, as neither the Clinical andLaboratory Standards Institute guidelines nor EUCAST
provides breakpoints for S. suis) and susceptible to the other
antimicrobial agents tested. Species identification was
further confirmed by sequence analysis of the 16S rRNA
gene. Polymerase chain reaction amplification of the nearly
complete 16S rRNA gene (1 475 bp) with two primers (8FPL
and 1492) was performed, as described previously [16, 32].
The amplification products were purified and sequenced.
The BLAST (Basic Local Alignment Search Tool) program
was used to compare the sequence of our isolates with those
in the GenBank and Ribosomal Database Project databases.
Sequencing of the 16S rRNA gene confirmed that the strain
belonged to the species S. suis with 99% nucleotide identity
compared with GenBank accession no. NR036918,
AF009487 and AM946016. The PCR-based results indicated
that our isolate possessed both tet(Q) the TC-resistance
determinant, and erm(B), the ML-resistance determinant
genes together.DISCUSSION AND REVIEW OF EUROPEAN
LITERATURE
S. suis is a Gram-positive, facultative anaerobic coccus, that
has been implicated as the cause of a wide range of clinical
diseases in swine and can be found in wide range of animal
species, including wild boars, horses, dogs, raccoon dogs, cats,
and birds [1–6]. In pigs, the natural habitat of S. suis is the
upper respiratory tract, particularly tonsils (tonsil carriage
rate in piglets aged 4–6 months was 32–50%), nasal cavities,
genital and alimentary tracts [33, 34], they could be healthy
carriers or afflicted. In contrast to the serotypes infecting pigs,
S. suis serotype 2 is the most common cause of this disease in
humans [33, 34]. S. suis infection normally occurs among
certain risk population particularly veterianers, hunters,
farmers, and abattoir works involving meat processing [1–6].
There is a wide clinical variation in the presentation of S. suis
infections in humans, but meningitis is the most common
clinical manifestation; S. suis can cause a very rare but serious
infection: there was a description of a large-scale STSS
outbreak among humans in China in 2005 caused by a single
clonal S. suis type 2 strain [35]. While pig-related occupation
is a main risk factor for human S. suis infection, exposure to
pigs or pig meat is not present in all of the cases of S. suis
infection, in Western countries. Although substantial new
data on the incidence, clinical and microbiological charac-
teristics, and risk factors for S. suis infection has been accu-
mulated during recent years, the prevalence of this infection
has not yet been described in Europe. In most European
countries, the infection rates among the exposed groups are
poorly known because S. suis infection is not a notifiable
disease, while only the United Kingdom and France consider
S. suis infections in humans as an industrial-risk disease.
During the last decade, the number of reported human cases
due to S. suis has dramatically increased, and most sporadic
human cases of infection appear to be due to close contact
with pigs/pork products, particularly in Western countries
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and so on). Two big epidemics were recorded in China, in
1998 and 2005 [35–37], but as of 2006, the number of human
cases reported in Asia has increased. S. suis is the most
common cause of adult meningitis in Vietnam, the second
most common in Thailand and the third most frequent cause
of community-acquired bacterial meningitis in Hong Kong
[35–37]. In Western countries, infections in humans mostly
occur sporadically.
We searched the PubMed/MEDLINE database using the
MeSH terms “Streptococcus suis” OR “Streptococcus suis
AND infection” with searching for human studies only,
without any time or language restrictions: we have found
1709 and 736 articles, respectively. If we narrowed our
search “Streptococcus suis infection Europe” we found only
58 articles. In addition to its first documentation from
Denmark, cases have been reported in The Netherlands [8,
38, 39], Italy [40–42], Spain [43–45], the United Kingdom
[46], Belgium [47], Croatia [48], Serbia [49], Austria [50],
Sweden [51], Germany [52–55], Poland [56], Hungary [18],
France [57], Greece [58–60], and Portugal [61], but some of
them are only available in their national languages. Sur-
prisingly, no cases have yet been published in Russia, despite
being a country with significant animal husbandry and
considerable pig production. Mancini et al. reported the first
human fatal case of STSS in Italy caused by S. suis serotype
2. The isolated strain was carrying a rare variation: tetra-
cycline efflux tet gene and the tetracycline ribosomal pro-
tection tet (O/W/32/O) gene together [62]. Their patient was
splenectomized, and in accordance with the clinical pa-
rameters of STSS, the case was characterized by multi-organ
dysfunction (MOD) and DIC [62].
Strangmann et al. published a case of septic shock from
Germany caused by S. suis type 2 in a 36-year-old man, who
was working as a truck driver transporting pigs preceding the
incident [63]. In the same study, 132 workers were involved in
pig slaughtering, pork dissecting and processing industries, to
assess the potential risk for an infection with S. suis [63]. In
their cross-sectional study, the otherwise healthy workers
were examined for the occurrence of S. suis in their pharynx,
and compared with an age and sex matched control group.
The colonization rate of case group with S. suis amounted to
5.3% [63]. In a study by Gustavsson et al., two patients
infected with the rare S. suis serotype 5 strains have been
documented: one of them was a 65-year-old pig farmer who
had cut his hand at work (while no cases were noted of severe
illness among his pigs, he had a history of benign hyperplasia
of the prostate gland he later developed septic arthritis in
Sweden [64]. Another interesting case was a pig farmer
without wounds or injuries in the US, who developed an
arthroplasty infection and STSLS [64]. According to
Schultsz et al., the S. suis serotype 2 is the main cause of
zoonotic S. suis infection in Netherlands despite the fact that
other serotypes are frequently isolated in their country from
pig-diseases [65]. Unfortunately, studies comparing concur-
rent pathogenic invasive human and different pig-isolates
(healthy colonizers or infected) from a single geographical
location are lacking. In the abovementioned Dutch study, thepopulation structures of invasive human S. suis strains iso-
lated between 1986 and 2008 (n 5 24) and from pigs with
invasive disease (n 5 124) were characterized by serotyping
and multilocus sequence typing (MLST) [65]. Most of the pig
isolates (56%) were of serotype 9, belonging to 15 clonal
complexes (CCs) or singleton sequence types (ST), but all of
the human isolates were of serotype 2 and they only belonged
into two non-overlapping clonal complexes CC1 (58%) and
CC20 (42%) [65]. Their results concluded that the rate of
serotype 2 isolates among S. suis strains from human patients
were significantly higher than among strains isolated from
pigs (24/24 vs. 29/124; P < 0.0001). They also established, that
the S. suis strain population isolated from infected pigs was
more diverse than the one isolated from human patients. The
S. suis serotype 2 strains of CC20 (which consisted 42% of all
human strains) were all negative for PCR detection of genes
encoding extracellular protein factor (EF) variants [65]. These
data indicate that the polysaccharide capsule was an impor-
tant factor regarding human S. suis infection, irrespective of
other genotypes and virulence factors of S. suis strains.
Princivalli et al. published a report in 2009, where two strains
from human meningitis in Sardinia and Northeastern Italy
was characterized for their genetics and antimicrobial sus-
ceptibility [66]. The abovementioned S. suis strains (the n5 2
recent human strains and n 5 57 swine clinical isolates were
collected between 2003 and 2007 from different Italian herds
and regions), were tested for their susceptibility patterns, for
virulence factors and antibiotic resistance genes using PCR
and they were also subjected to molecular typing. Their study
demonstrated an overall high genetic diversity among isolates,
the majority of which were resistant to macrolides (78%) and
tetracyclines (90%). The erm(B), tet(O), mosaic tet(O/W/32/
O), tet(W), and tet(M) genes were detected [66]. The tet(O/
W/32/O) gene was first described in the genus Streptococcus
in this publication which was the most frequent tet gene after
tet(O) [66]. A virulent clone belonging to sequence type 1
(ST1) of the ST1 complex was found to be prevalent and
persistent in Italian swine herds, but the two human isolates
(both ST1) carrying cps2, erm(B) and tet(W) were seen to be
closely related to each other. The very interesting finding that
invasive and non-invasive isolates share identical virulence
profiles seems to support the conclusions of earlier publica-
tions that some other, yet unknown virulence factors are
responsible for the pathogenic potential of S. suis [66]. In one
of the few available retrospective report from Eastern-Euro-
pean countries, Bojarska et al. performed a retrospective
analysis of S. suis human invasive isolates, collected by the
National Reference Centre for Bacterial Meningitis in Poland
[67]. In this report, isolates obtained from 21 patients during
2000–2013 were investigated by phenotypic biochemical tests
and multilocus sequence typing (MLST): 48% of cases were
misdiagnosed/misidentified by a microbiological laboratory
who submitted the strains. All investigated isolates were
members of the ST1 and were suggested to be serotype 2,
most of the isolates were a-hemolytic, DNase-positive and
little less, than half of them could form biofilm. Genes
encoding suilysin, EPF, FBP, MRP, surface antigen one,
enolase, OFS, and pili were ubiquitous in the studied group of
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teristic for the 89K pathogenicity island [67]. In this report,
fatal hyperacute infections with shock have also been
described and a high mortality rate, especially in the case of
the STSLS, closely associated with the 2005 Chinese epidemic,
but also observed independently. The authors expressed the
opinion that the real morbidity due to S. suis in Poland, a
country with a well-developed swine industry (over 10 million
units), is very likely underestimated [67]. Manzin et al.
described a severe case in a 68-year-old retired welder of S.
suis meningitis from Sardinia, Italy, who interestingly had no
reported contact with swine, other animals or any animal
products [68]. However, as described in the case, the patient
had cancer, which was discovered incidentally during the
workup: a computer tomography scan, bronchoscopy and
histopathologic findings led to diagnosis of the mass as an
advanced-stage squamous cell carcinoma [68]. As reported
already for Group B Streptococcus, splenectomy, alcoholism,
diabetes mellitus and malignancy have been suggested as
important predisposing factors for the development of
serious, often rapid, fatal S. suis diseases [45, 68, 69–72].
Indeed, many S. suis cases have been described in individuals
who had suffered splenectomy, furthermore, the mortality
rate of S. suis infection after splenectomy is nearly 80% [1–6,
45, 69–72].
Although the colonization rate of S. suis in swine and
wild boars is well-known and characterized (85–100%), the
reports on the epidemiology of invasive S. suis infections in
these animals in Europe (especially Hungary) are scarce
[73]. Interestingly, while there is significant geographical
variation in the prevalence of human S. suis cases (cases
from Europe only account for about 8–9% of cases), the
epidemiological variations in pig infections are far less
pronounced [74]. Transmission of this pathogen is usually
through the respiratory system in the form of direct nose-to-
nose contact (horizontal transmission), however, vertical
transmission through the genital tract during farrowing has
also been described [75, 76]. Susceptible pigs (especially
piglets during their weaning, may suffer from meningitis,
septicemia, pneumonia, endocarditis, or polyarthritis; the
molecular pathogenesis of these diseases in pigs is similar to
their human counterparts [73, 77]. A study reporting on the
significant factors of piglet mortality in Europe (including
Hungary) has already highlighted the role of S. suis in-
fections as an economic burden for the industry [78], while
later a report noted the relevance of this bacterium as an
occupational hazard [79]. In a Hungarian large breeding
unit of >3,000 sows, an interventional study was performed
regarding S. suis Serotype 2 vaccination because of severe
animal losses due to S. suis disease; as a result, pre-weaning
mortality was significantly reduced the vaccinated groups of
pigs (both in groups vaccinated 3 or 6 weeks after parturi-
tion) [80]. Similar antibiotics may be used for the therapy of
S. suis disease in pigs like in humans, additionally, a 3rd
generation cephalosporin (ceftiofur) for veterinary use only
is licenced for this exact indication [73].
In conclusion, we have described the first fatal human
case of S. suis infection in Hungary (with a rapidly-progrediating disease course), where the pathogen was
extensively characterized both microbiologically and genet-
ically. To our knowledge, this is the second Hungarian
published case, however due to Hungary’s pronounced
traditional agriculture, which primarily includes pork,
prevalent pig-meat consumption customes and disadvanta-
geous epidemiological characteristics (high levels of alcohol
consumption, diabetes mellitus, obesity and one of the
highest incidence of malignancies worldwide), which have
all been described as important predisposing factors for the
development of serious, often fatal outcome in this infection.
So far, some reports of S. suis infections have only been
presented at national congresses. In the database of the
National Bacteriological Surveillance (NBS) in Hungary,
there have been 17 reports of these bacteria in invasive
samples (i.e., blood cultures, cerebrospinal fluids) over a 15-
year period [81, 82]. Therefore, one invasive case should be
expected annually, based on national surveillance data.
It seems that our patient acquired the infection through
his skin wounds caused by a pig bone. As the patient had
splenectomy several years before this injury, he was more
prone to rare infections. His clinical symptoms presented
as an invasive deep-tissue infection with STSS, character-
ized by acute high fever, vascular collapse, hypotension,
DIC, shock, multiple organ failure, and despite the fact that
he was a young, although obese but otherwise healthy
strong man, finally resulted in a very rapid deterioration
and at last death. Although the isolation rate for these
bacteria is still very low in European countries, clinicians
should be aware of the emergence of S. suis infections
especially in immunocompromised patients. Since first
described in Denmark in 1968, over 1,600 human cases of
S. suis infection have been reported however on the basis of
European data about the prevalence of S. suis, we assume
that this infection is underdiagnosed in most European
countries. Misidentification of S. suis is very common: this
bacterium is frequently misidentified as Streptococci vir-
idans [14] and has also been misidentified as Streptococcus
bovis, Streptococcus pneumoniae, Streptococcus faecalis, and
Streptococcus acidominimus [2, 6, 21, 83]. Misidentification
of S. suis also has been reported in Canada, which raises
suspicion that human S. suis infections might be under-
diagnosed in North America [84, 85]. In the report by
Tarini et al., a previously healthy 50-year-old man was
admitted to one of the district hospitals in Bali Province,
Indonesia, due to meningitis. The patient had a history of
consuming homemade raw pork product two days before
the onset of illness. Streptococcus mitis was identified
from the cerebrospinal fluid culture by using VITEK 2
COMPACT (Biomeriuex) with a 99% probability score.
This patient had clinical symptoms and risk factor identical
to S. suis infection, so they performed confirmation tests
for the cerebrospinal fluid by PCR (using primer specific
for gdh and recN) and sequencing of those PCR products,
both of the confirmation tests showed a positive result for
S. suis [86]. Finally, the use of modern diagnostic methods,
such as MALDI-TOF, targeted directly from clinical iso-
lates could identify correctly the strain, as well as PCR can
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chemically inactive species [87].
Our study highlights that in non-endemic areas, infec-
tion with this pathogen, although not frequently reported,
should be considered when diagnosis is made for patients
who work in piggeries. In conclusion, clinicians should be
aware of this microorganism when examining and treating
patients with fever, who are handling raw pork or having
close contact with infected pigs even if they are immuno-
competent. People in risk groups should be educated and
made aware of this infection. Patients with an increased risk
of infection, e.g., because of splenectomy or use of immu-
nosuppressive medication, should avoid direct pig or pork
contact when skin lesions-particularly on the hands-are
present. Skin protection has been suggested to reduce the
incidence of S. suis infection. On the basis of this case, the
necessity of vaccination should have arisen in the case of
patients with splenectomy.
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